Proteomic toolbox for autoimmunity research

Autoimmunity Reviews

Volumn 8, Issue 7, 2009, Pages 595-598

  Wu, Tianfu ^a   Mohan, Chandra ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Lupus; Protein microarray; Rheumatoid arthritis

Indexed keywords

CALGRANULIN A; CALGRANULIN B;

AUTOIMMUNITY; DISEASE MARKER; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL RESEARCH; NONHUMAN; PROTEIN MICROARRAY; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; MASS SPECTROMETRY; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 67349210321     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.01.019     Document Type: Review

References (34)

1. Hueber W., and Robinson W.H. Proteomic biomarkers for autoimmune disease. Proteomics 6 (2006) 4100-4105
2. Baldini C., Giusti L., Bazzichi L., Lucacchini A., and Bombardieri S. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjogren's syndrome?. Autoimmun Rev 7 (2008) 185-191
3. Villalta D., Tozzoli R., Tonutti E., and Bizzaro N. The laboratory approach to the diagnosis of autoimmune diseases: is it time to change?. Autoimmun Rev 6 (2007) 359-365
4. Petrovsky N., and Brusic V. Bioinformatics for study of autoimmunity. Autoimmunity 39 (2006) 635-643
5. Hershko A.Y., and Naparstek Y. Autoimmunity in the era of genomics and proteomics. Autoimmun Rev 5 (2006) 230-233
6. Sinz A., Bantscheff M., Mikkat S., Ringel B., Drynda S., Kekow J., et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 23 (2002) 3445-3456
7. Oates J.C., Varghese S., Bland A.M., Taylor T.P., Self S.E., Stanislaus R., et al. Prediction of urinary protein markers in lupus nephritis. Kidney Int 68 (2005) 2588-2592
8. Giusti L., Baldini C., Bazzichi L., Ciregia F., Tonazzini I., Mascia G., et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases-the example of Sjogren's syndrome. Proteomics 7 (2007) 1634-1643
9. Okunuki Y., Usui Y., Takeuchi M., Kezuka T., Hattori T., Masuko K., et al. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease. Exp Eye Res 84 (2007) 823-831
10. Liao H., Wu J., Kuhn E., Chin W., Chang B., Jones M.D., et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 50 (2004) 3792-3803
11. Peluso G., De Santis M., Inzitari R., Fanali C., Cabras T., Messana I., et al. Proteomic study of salivary peptides and proteins in patients with Sjogren's syndrome before and after pilocarpine treatment. Arthritis Rheum 56 (2007) 2216-2222
12. Mosley K., Tam F.W., Edwards R.J., Crozier J., Pusey C.D., and Lightstone L. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology (Oxford) 45 (2006) 1497-1504
13. Liu T., Donahue K.C., Hu J., Kurnellas M.P., Grant J.E., Li H., et al. Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord. J Proteome Res 6 (2007) 2565-2575
14. Joos T.O., Schrenk M., Hopfl P., Kroger K., Chowdhury U., Stoll D., et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 21 (2000) 2641-2650
15. Robinson W.H., DiGennaro C., Hueber W., Haab B.B., Kamachi M., Dean E.J., et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 8 (2002) 295-301
16. Li Q.Z., Xie C., Wu T., Mackay M., Aranow C., Putterman C., et al. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 115 (2005) 3428-3439
17. Wu T., Xie C., Bhaskarabhatla M., Yan M., Leone A., Chen S.S., et al. Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum 56 (2007) 949-959
18. Wu T., Xie C., Wang H.W., Zhou X.J., Schwartz N., Calixto S., et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol 179 (2007) 7166-7175
19. Bauer J.W., Baechler E.C., Petri M., Batliwalla F.M., Crawford D., Ortmann W.A., et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med 3 (2006) e491
20. Lefranc D., Launay D., Dubucquoi S., de Seze J., Dussart P., Vermersch M., et al. Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum 56 (2007) 3420-3432
21. Wu T., Qin X., Kurepa Z., Kumar K.R., Liu K., Kanta H., et al. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest 117 (2007) 2186-2196
22. Irish J.M., Hovland R., Krutzik P.O., Perez O.D., Bruserud O., Gjertsen B.T., et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118 (2004) 217-228
23. O'Neill R.A., Bhamidipati A., Bi X., Deb-Basu D., Cahill L., Ferrante J., et al. Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc Natl Acad Sci U S A 103 (2006) 16153-16158
24. Gronborg M., Kristiansen T.Z., Iwahori A., Chang R., Reddy R., Sato N., et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5 (2006) 157-171
25. Amanchy R., Kalume D.E., Iwahori A., Zhong J., and Pandey A. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC). J Proteome Res 4 (2005) 1661-1671
26. Everley P.A., Krijgsveld J., Zetter B.R., and Gygi S.P. Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics 3 (2004) 729-735
27. Gu S., Liu Z., Pan S., Jiang Z., Lu H., Amit O., et al. Global investigation of p53-induced apoptosis through quantitative proteomic profiling using comparative amino acid-coded tagging. Mol Cell Proteomics 3 (2004) 998-1008
28. Yan W., Lee H., Deutsch E.W., Lazaro C.A., Tang W., Chen E., et al. A dataset of human liver proteins identified by protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry. Mol Cell Proteomics 3 (2004) 1039-1041
29. Du Z., Colls N., Cheng K.H., Vaughn M.W., and Gollahon L. Microfluidic-based diagnostics for cervical cancer cells. Biosens Bioelectron 21 (2006) 1991-1995
30. Chambraud B., Radanyi C., Camonis J.H., Rajkowski K., Schumacher M., and Baulieu E.E. Immunophilins, Refsum disease, and lupus nephritis: the peroxisomal enzyme phytanoyl-COA alpha-hydroxylase is a new FKBP-associated protein. Proc Natl Acad Sci U S A 96 (1999) 2104-2109
31. Lalvani A., Meroni P.L., Millington K.A., Modolo M.L., Plebani M., Tincani A., et al. Recent advances in diagnostic technology: applications in autoimmune and infectious diseases. Clin Exp Rheumatol 26 (2008) S62-66
32. Wu T., and Mohan C. Proteomics on the diagnostic horizon: lessons from rheumatology. Am J Med Sci 333 (2007) 16-25
33. Kalbas M., Lueking A., Kowald A., and Muellner S. New analytical tools for studying autoimmune diseases. Curr Pharm Des 12 (2006) 3735-3742
34. Garcia-Ramirez M., Canals F., Hernandez C., Colome N., Ferrer C., Carrasco E., et al. Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 50 (2007) 1294-1303